Sientra Announces Completion and Winning Bidders of its Section 363 Sales Auction
02 avr. 2024 18h30 HE
|
Sientra, Inc.
Tiger Aesthetics Medical, LLC is the successful bidder for certain assets used in Sientra’s breast reconstruction and augmentation business Nuance Intermediary, LLC is the successful bidder for...
Sientra to Pursue Strategic Sale of its Business Through Voluntary Chapter 11 Process
13 févr. 2024 08h30 HE
|
Sientra, Inc.
IRVINE, Calif., Feb. 13, 2024 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a surgical aesthetics company developing and commercializing safe and innovative...
Sientra Reports Third Quarter Financial and Operational Results
09 nov. 2023 16h05 HE
|
Sientra, Inc.
IRVINE, Calif., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a surgical aesthetics company developing the safest and most innovative solutions for the...
Sientra to Present at the Stifel 2023 Healthcare Conference
08 nov. 2023 08h35 HE
|
Sientra, Inc.
IRVINE, Calif., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a surgical aesthetics company developing the safest and most innovative solutions for the...
Sientra Reports Preliminary Unaudited Third Quarter 2023 Financial Results and Provides Update on Outlook
30 oct. 2023 17h00 HE
|
Sientra, Inc.
IRVINE, Calif., Oct. 30, 2023 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a surgical aesthetics company delivering the safest and most innovative solutions for the...
Sientra Reports Record Second Quarter Financial and Operational Results
10 août 2023 16h03 HE
|
Sientra, Inc.
Revenue growth of 7.5% driven by continued market share gains in reconstruction and augmentation Best operational results in company history with 95% and 63% year-over-year improvement inoperating...
Sientra to Report Second Quarter 2023 Financial Results on August 10, 2023
27 juil. 2023 04h05 HE
|
Sientra, Inc.
IRVINE, Calif., July 27, 2023 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN)(“Sientra” or the “Company”), a medical aesthetics company developing the safest and most innovative solutions for the...
Sientra Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
30 juin 2023 16h42 HE
|
Sientra, Inc.
IRVINE, Calif., June 30, 2023 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ:SIEN) (“Sientra” or the “Company”), a medical aesthetics company uniquely focused on plastic surgeons, today announced that...
Sientra Announces Appointment of Alexander W. Casdin to Board of Directors
20 juin 2023 08h35 HE
|
Sientra, Inc.
IRVINE, Calif., June 20, 2023 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company focused on enhancing lives by advancing the art of plastic...
Sientra Announces FDA-Clearance of Next Generation AlloX2 Pro™ Tissue Expander
08 juin 2023 16h05 HE
|
Sientra, Inc.
Significant Milestone as the First, and Only, MRI-Compatible Tissue Expander Available on the US Market Continues Sientra’s Leadership and Innovation in Breast Reconstruction IRVINE, Calif., June ...